FDA approves new treatment for relapsed follicular lymphoma
On Sept. 14, the U.S. Food and Drug Administration (FDA) granted accelerated approval to Aliqopa (copanlisib) for the treatment of adults with relapsed follicular…
News
Missed nursing care increases risk of postop mortality
Missed nursing care because of inadequate staffing increases postoperative patients’ risk of dying within 30 days of hospital admission, according to a report in…
FDA clears patient-assisted mammography system
On Sept. 1, the U.S. Food and Drug Administration (FDA) cleared the first 2D digital mammography system that allows patients to increase or decrease…
FDA approves new drug for acute myeloid leukemia
On Sept. 1, the U.S. Food and Drug Administration (FDA) approved Mylotarg (gemtuzumab ozogamicin) for the treatment of adults with newly diagnosed acute myeloid…
CDC urges early recognition, prompt treatment of sepsis
The Centers for Disease Control and Prevention has launched Get Ahead of Sepsis, an educational initiative to protect Americans from the devastating effects of…
Secrets, lies, and cover-ups
The impact of the new healthcare bill can’t be hidden forever. By Leah Curtin, RN, ScD(h), FAAN As Newton observed, for every action in…
FDA approved first gene therapy in U.S.
“We’re entering a new frontier in medical innovation with the ability to reprogram a patient’s own cells to attack a deadly cancer,” said FDA…
FDA approves new drug for UTI
“The FDA is committed to making new safe and effective antibacterial drugs available,” said Edward Cox, M.D., director of the Office of Antimicrobial Products…
FDA announces plans to evaluate use of opioids for treating cough in children
On Aug. 21, the U.S. Food and Drug Administration (FDA) announced that an upcoming meeting of the pediatric advisory committee will focus on the…
FDA approves new treatment for adults with relapsed or refractory acute lymphoblastic leukemia
On Aug. 17, the U.S. Food and Drug Administration (FDA) approved Besponsa (inotuzumab ozogamicin) for the treatment of adults with relapsed or refractory B-cell…
Nurses’ knowledge of postpartum complications needs improvement
A study in MCN notes that most nurses who care for women during the postpartum period aren’t current on the rates and timing of…
Probiotics may prevent sepsis in infants
A randomized, double-blind, placebo-controlled trial reported in Nature notes that combining a probiotic with fructo-oligosaccharide significantly reduces sepsis and mortality in newborns in rural…
FDA approves new treatment for relapsed follicular lymphoma
On Sept. 14, the U.S. Food and Drug Administration (FDA) granted accelerated approval to Aliqopa (copanlisib) for the treatment of adults with…
Missed nursing care increases risk of postop mortality
Missed nursing care because of inadequate staffing increases postoperative patients’ risk of dying within 30 days of hospital admission, according to a…
FDA clears patient-assisted mammography system
On Sept. 1, the U.S. Food and Drug Administration (FDA) cleared the first 2D digital mammography system that allows patients to increase…
FDA approves new drug for acute myeloid leukemia
On Sept. 1, the U.S. Food and Drug Administration (FDA) approved Mylotarg (gemtuzumab ozogamicin) for the treatment of adults with newly diagnosed…
CDC urges early recognition, prompt treatment of sepsis
The Centers for Disease Control and Prevention has launched Get Ahead of Sepsis, an educational initiative to protect Americans from the devastating…
Secrets, lies, and cover-ups
The impact of the new healthcare bill can’t be hidden forever. By Leah Curtin, RN, ScD(h), FAAN As Newton observed, for every…
FDA approved first gene therapy in U.S.
“We’re entering a new frontier in medical innovation with the ability to reprogram a patient’s own cells to attack a deadly cancer,”…
FDA approves new drug for UTI
“The FDA is committed to making new safe and effective antibacterial drugs available,” said Edward Cox, M.D., director of the Office of…
FDA announces plans to evaluate use of opioids for treating cough in children
On Aug. 21, the U.S. Food and Drug Administration (FDA) announced that an upcoming meeting of the pediatric advisory committee will focus…
FDA approves new treatment for adults with relapsed or refractory acute lymphoblastic leukemia
On Aug. 17, the U.S. Food and Drug Administration (FDA) approved Besponsa (inotuzumab ozogamicin) for the treatment of adults with relapsed or…
Nurses’ knowledge of postpartum complications needs improvement
A study in MCN notes that most nurses who care for women during the postpartum period aren’t current on the rates and…
Probiotics may prevent sepsis in infants
A randomized, double-blind, placebo-controlled trial reported in Nature notes that combining a probiotic with fructo-oligosaccharide significantly reduces sepsis and mortality in newborns…
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.
NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.